Drug Interactions between acetaminophen / dextromethorphan / guaifenesin / phenylephrine and Azithromycin Dose Pack
This report displays the potential drug interactions for the following 2 drugs:
- Azithromycin Dose Pack (azithromycin)
Interactions between your drugs
No interactions were found between acetaminophen / dextromethorphan / guaifenesin / phenylephrine and Azithromycin Dose Pack. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
acetaminophen / dextromethorphan / guaifenesin / phenylephrine
A total of 472 drugs are known to interact with acetaminophen / dextromethorphan / guaifenesin / phenylephrine.
- Acetaminophen / dextromethorphan / guaifenesin / phenylephrine is in the drug class upper respiratory combinations.
- Acetaminophen / dextromethorphan / guaifenesin / phenylephrine is used to treat the following conditions:
Azithromycin Dose Pack
- Azithromycin dose pack is in the drug class macrolides.
Azithromycin dose pack is used to treat the following conditions:
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Chlamydia Infection
- COPD, Acute
- Cystic Fibrosis
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Legionella Pneumonia
- Lyme Disease, Erythema Chronicum Migrans
- Mycobacterium avium-intracellulare, Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Otitis Media
- Pelvic Inflammatory Disease
- Pertussis Prophylaxis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- STD Prophylaxis
- Typhoid Fever
- Upper Respiratory Tract Infection
Drug and food interactions
No interactions were found. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|